BRII BIOSCIENCES L
(HKEX: 2137)
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
1.580 -
-0.010
(-0.63%)
Range
1.560 - 1.610
(3.21%)
Open
1.590
Previous Close
1.590
Bid Price
1.560
Bid Volume
('000)
1,018
Ask Price
1.590
Ask Volume
('000)
3
Volume
('000)
1,437
Value
2,267,080
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
